RY
Ryman Healthcare Limited
RYHTY · OTC
$6.11 +0.00% (+$0.00)
Market Cap $2.19B
P/E Ratio -
Div. Yield -
ROE 10.42%
Bulios Fair Price
$4.64
24.1% downside
Current Price
$6.11
Undervalued Fair Value Overvalued
According to Bulios Fair Price, RYHTY is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
4/9Valuation
90 /100
Cheap P/B 0.51x
P/FCF 7.24x
P/S 3.07x
Growth
68 /100
Growing FCF growth 8.47%
Book val. growth 7.45%
Rev. growth 12.32%
Profitability
50 /100
Moderate Net margin 61.20%
Op. margin 16.57%
FCF margin 42.43%
Quality
1 /100
Poor ROE 10.42%
ROA 3.62%
Asset turnover 0.06x
Debt
42 /100
Moderate Current ratio 0.24x
Int. coverage -0.54x
Debt/Equity 0.40x
Stability
40 /100
Moderate Rev. volatility 3.36%
EPS volatility 5,115.56%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about RYHTY
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Naomi James
Employees
7,800
Headquarters
Christchurch